Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Director/PDMR Shareholding

29 Oct 2018 07:00

RNS Number : 3880F
Harvey Nash Group PLC
29 October 2018
 

29 October 2018

 

Director/PDMR Shareholding

Harvey Nash Group Plc

("the Company")

Notification of Transaction by Directors

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company was advised on 26 October 2018 that Albert Ellis, Simon Wassall and Mark Garratt had acquired ordinary shares in London on 26 October 2018 at a price of £0.05 per ordinary share as a result of the exercise of options granted under the Company's Performance Share Plan which became exercisable as a result of the offer by The Power of Talent Ltd being declared wholly unconditional on 26 October 2018:

Director

Number of shares purchased

Price per share

Resulting holding

Albert Ellis

1,385,499

£0.05

2,267,084*

Simon Wassall

930,215

£0.05

1,259,331

Mark Garratt

381,229

£0.05

416,787

*Includes 658,923 ordinary shares held by family members.

The notification below provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1

Details of the person discharging managerial responsibility

a)

Name

Albert Ellis

2

Reason for the notification

a)

Position/status

Chief Executive

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

1,385,499

£69,274.95

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Simon Wassall

2

Reason for the notification

a)

Position/status

European Managing Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

930,215

£46,510.75

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Mark Garratt

2

Reason for the notification

a)

Position/status

Group Finance Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

381,229

£19,061.45

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

Contact:

Mark Garratt, Group Finance Director - 020 7333 0033

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFEUFMMFASEES
Date   Source Headline
19th Jun 201411:20 amRNSHolding(s) in Company
12th Jun 20147:00 amRNSBlocklisting Interim Review
5th Jun 20147:00 amRNSInterim Management Statement
2nd Jun 20149:45 amRNSDirector/PDMR Shareholding
2nd Jun 20147:00 amRNSTotal Voting Rights
20th May 20149:44 amRNSHarvey Nash CIO Survey 2014
8th May 20145:20 pmRNSHolding(s) in Company
1st May 20147:00 amRNSTotal Voting Rights
30th Apr 20145:10 pmRNSDirector/PDMR Shareholding
25th Apr 20147:00 amRNSFinal Results
14th Apr 20149:00 amRNSPreliminary Results Briefing for Analysts
1st Apr 20147:00 amRNSTotal Voting Rights
28th Mar 20144:29 pmRNSDirector/PDMR Shareholding
11th Mar 20149:29 amRNSHolding(s) in Company
3rd Mar 201412:23 pmRNSDirector/PDMR Shareholding
28th Feb 20147:02 amRNSDirectorate Appointment
28th Feb 20147:00 amRNSTotal Voting Rights
20th Feb 20147:00 amRNSTrading Update and Notice of Results
19th Feb 201412:06 pmRNSEBT Share Transfers
3rd Feb 20142:35 pmRNSDirector/PDMR Shareholding
31st Jan 20147:00 amRNSTotal Voting Rights
9th Jan 201412:04 pmRNSHolding(s) in Company
2nd Jan 20147:00 amRNSTotal Voting Rights
23rd Dec 201310:18 amRNSDirector/PDMR Shareholding
20th Dec 20134:56 pmRNSEBT Share Purchase
20th Dec 20134:17 pmRNSBlocklisting Interim Review
4th Dec 201310:08 amRNSDirector/PDMR Shareholding
2nd Dec 20132:49 pmRNSDirector/PDMR Shareholding
2nd Dec 20137:00 amRNSTotal Voting Rights
29th Nov 20137:01 amRNSDirectorate Change
29th Nov 20137:00 amRNSInterim Management Statement
1st Nov 20137:00 amRNSTotal Voting Rights
28th Oct 20134:10 pmRNSDirector/PDMR Shareholding
7th Oct 201311:05 amRNSHolding(s) in Company
1st Oct 201310:12 amRNSEBT Share Purchase
1st Oct 20139:41 amRNSDirector shareholding
1st Oct 20137:00 amRNSTotal Voting Rights
27th Sep 20137:00 amRNSHalf Yearly Report
23rd Sep 20133:41 pmRNSHolding(s) in Company
2nd Sep 20137:00 amRNSTotal Voting Rights
30th Aug 20133:42 pmRNSDirector/PDMR Shareholding
20th Aug 20137:00 amRNSTrading Update
1st Aug 20137:00 amRNSTotal Voting Rights
31st Jul 20132:42 pmRNSDirector/PDMR Shareholding
2nd Jul 20139:49 amRNSDirector/PDMR Shareholding
1st Jul 20137:00 amRNSTotal Voting Rights
24th Jun 201312:51 pmRNSDirector/PDMR Shareholding
20th Jun 20133:03 pmRNSDirectorate Change
20th Jun 20132:41 pmRNSResult of AGM
12th Jun 20137:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.